Earnings FeedTerminal

⌘K

Home/Filings/8-K/0001181431-05-037472

8-K//Current report

GENAERA CORP 8-K

Accession 0001181431-05-037472

CIK 0000880431operating

View on SEC.gov Company Profile

Filed

Jun 29, 8:00 PM ET

Accepted

Jun 30, 10:25 AM ET

Size

27.3 KB

Accession

0001181431-05-037472

Documents

2 files

8-K
rrd84200.htmPrimary
EX-99.1
rrd84200_6653.htm
PRESS RELEASE OF THE COMPANY DATED JUNE 30, 2005- "GENAERA INITIATES PHASE III MACULAR DEGENERATION CLINICAL TRIAL FOR EVIZON(TM)."

Issuer

GENAERA CORP

CIK 0000880431

Entity typeoperating

IncorporatedDE

Related Parties

1

filerCIK 0000880431

Filing Metadata

Form type: 8-K
Filed: Jun 29, 8:00 PM ET
Accepted: Jun 30, 10:25 AM ET
Size: 27.3 KB

View on SEC.gov